Guggenheim Maintains Buy on Veracyte, Raises Price Target to $65

Veracyte, Inc.

Veracyte, Inc.

VCYT

0.00

Guggenheim analyst Subbu Nambi maintains Veracyte (NASDAQ: VCYT) with a Buy and raises the price target from $45 to $65.